Construction of interleukin-1α mutants using unequal contamination of synthetic oligonucleotides
- 1 January 1991
- journal article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 19 (8) , 1899-1904
- https://doi.org/10.1093/nar/19.8.1899
Abstract
Proteins without readily available three-dimensional structural data present a difficult problem in the exploration of structure/function relationships. Saturation mutagenesis using contaminated oligonucleotides can identify potentially interesting regions of such a protein. This technique, in which synthesized oligonucleotides contain low-level base substitutions, allows random mutations to be placed throughout a gene sequence. Using double-stranded cassettes, a region of the human interleukin-1 alpha gene has been altered using such mutagenic oligonucleotides. However, instead of contaminating both strands of the gene sequence at the same level, each strand of the insert was contaminated at a different level. Several recombinants were sequenced and the effects of the mutations on the activity of the proteins were examined. Contaminating the two oligonucleotides at different levels produced a significantly different distribution of nucleotide changes from that seen if both strands were contaminated at the same level. The observed distribution followed the average of the distributions for each of the two contamination levels. This resulted in roughly equal frequencies of 1 to 5 nucleotide changes per clone with very few clones containing the wild-type nucleotide sequence. This helped overcome the redundancy in the genetic code, resulting in a high frequency of amino acid changes, and allowed changes at every amino acid to be sampled in a small number of mutants. This procedure can allow a gene sequence to be screened rapidly by removing most wild-type sequences from analysis while making sure that there are many amino acid changes in the resultant mutants.Keywords
This publication has 14 references indexed in Scilit:
- A HUMAN IL-1-ALPHA DERIVATIVE WHICH LACKS PROSTAGLANDIN-E2 INDUCING ACTIVITY AND INHIBITS THE ACTIVITY OF IL-1 THROUGH RECEPTOR COMPETITION1990
- A point mutation uncouples human interleukin-1 beta biological activity and receptor binding.Journal of Biological Chemistry, 1990
- Identifying determinants of folding and activity for a protein of unknown structure.Proceedings of the National Academy of Sciences, 1989
- Random oligonucleotide mutagenesis: application to a large protein coding sequence of a major histocompatibility complex class I gene,H-2DPNucleic Acids Research, 1988
- Cloning, sequence and expression of bovine interleukin 1α and interleukin 1β complementary DNAsMolecular Immunology, 1988
- The role of computer simulation techniques in protein engineeringProtein Engineering, Design and Selection, 1988
- Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta.Proceedings of the National Academy of Sciences, 1987
- The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor.Journal of Biological Chemistry, 1987
- Saccharomyces cerevisiae CYC1 mRNA 5'-end positioning: analysis by in vitro mutagenesis, using synthetic duplexes with random mismatch base pairs.Molecular and Cellular Biology, 1985
- Genetic studies of the lac repressorJournal of Molecular Biology, 1977